SCHEMBL24106136

SCHEMBL24106136

C=C(C)C(=O)OC(C)c1cc(I)c(O)c(OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.44
▸ LMNA P02545 1/20 0.41
▸ PTGS2 P35354 1/20 0.36
▸ TRPV1 Q8NER1 1/20 0.34
▸ HIF1A Q16665 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ BLM P54132 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ RGS12 O14924 1/20 0.34
▸ GMNN O75496 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ ALPL P05186 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ ALPI P09923 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24106153 0.83 TUBB4A (0.35) HIF1AALDH1A1KMT2AMEN1MAPT
SCHEMBL26816149 0.82 HIF1A (0.36) LMNAHIF1AKMT2ATSHRBLM
SCHEMBL38657965 0.82 HIF1A (0.36) LMNAHIF1AKMT2ATSHRBLM
SCHEMBL24908562 0.82 APP (0.40) APPLMNAPTGS2TRPV1HIF1A
SCHEMBL24106321 0.80 CYP3A4 (0.38) LMNAPTGS2TSHRBLMUSP2
SCHEMBL38657378 0.78 BPTF (0.37) LMNAHIF1AKMT2AMAPK1L3MBTL1
SCHEMBL24106313 0.78 LMNA (0.37) APPLMNAPTGS2KDM4EALDH1A1
SCHEMBL26861530 0.78 TSHR (0.52) KMT2ATSHRBLMMEN1CYP3A4
SCHEMBL24589109 0.78 APP (0.43) APPLMNAPTGS2TRPV1HIF1A
SCHEMBL29695951 0.78 APP (0.43) APPLMNAPTGS2TRPV1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026100410-A1 IODINE-CONTAINING POLYMERIZABLE COMPOUND AND IODINE-CONTAINING POLYMER 三菱瓦斯化学株式会社 2026-05-15 — — WO disclosed
US-11822244-B2 Compound, resin, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-11-21 — — US disclosed
US-11822244-B2 Compound, resin, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-11-21 — — US disclosed
US-20210389669-A1 COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-12-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210389669-A1 COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN RER1, AFF1, AFF4 APP 2604/4885LMNA 3320/4885PTGS2 3793/4885
US-11822244-B2 Compound, resin, resist composition and method for producing resist pattern RER1, AFF1, AFF4 APP 2604/4885LMNA 3320/4885PTGS2 3793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback